Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 306 of 5804
-
Simple blood test could spare prostate cancer patients from unnecessary scans
Diagnosis Recruiting nowBrief Summary: This prospective, multicenter study aims to discover, develop, and validate a plasma exosomal RNA-based signature as a rule-out test for predicting bone metastasis in prostate cancer, using baseline treatment-naïve PSMA PET as the gold standard. The study is desig…
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Triple threat: immunotherapy and targeted drug join forces against esophageal cancer
Disease control Recruiting nowThis trial is conducted in patients with resectable locally advanced esophageal squamous cell carcinoma. The investigators plan to enroll 46 patients with resectable locally advanced esophageal cancer in Tianjin cancer hospital. Patients will be treated with serplulimab, nimotuzu…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New malaria vaccine trial aims to block infection without causing illness
⭐️ VACCINE ⭐️ Recruiting nowThis is a randomized, double-blind, placebo-controlled Phase 1 trial of Plasmodium falciparum (Pf) sporozoite (SPZ) late-arresting replication-competent (LARC) malaria vaccine (PfSPZ-LARC2 Vaccine) administered to healthy, malaria-naive study participants in Germany by direct ven…
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:01 UTC
-
Breakthrough study aims to spare rectal cancer patients from surgery
Disease control Not yet recruitingThis study evaluates whether mesorectal chemoradiotherapy with a limited radiation target volume can achieve a sustained clinical complete response in patients with early-stage rectal cancer, allowing surgery to be safely deferred. Patients may choose between standard total mesor…
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immunotherapy combo trial aims to boost survival in head and neck cancer
Disease control Recruiting nowThis phase II randomized trial compares the efficacy and safety of Toripalimab combined with three different platinum-based induction chemotherapy regimens, sequentially followed by standard concurrent chemoradiotherapy, for the treatment of locally advanced nasopharyngeal carcin…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for bladder cancer: experimental drug trial now recruiting
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404. It is for adults with a type of bladder cancer called locally advanced or metastatic urothelial cancer (LA/mUC), meaning the cancer has spread to nearby tissues or other parts of the body. The purpos…
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug combo aims to boost chemo for tough bone cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether adding gefitinib, trametinib, disulfiram, and sunitinib to standard chemotherapy is a more effective treatment approach for people with osteosarcoma than standard chemotherapy on its own. The researchers will also look at t…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI ultrasound could revolutionize breast cancer screening in poor regions
Diagnosis Recruiting nowTo assess the feasibility, safety, and clinical performance of community-based breast cancer screening incorporating clinical breast exam and short-termed trained examiners performing AI-supported breast POCUS for triage in limited-resource settings.
Phase: NA • Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Can a 12-Week program reverse type 2 diabetes in family doctor offices?
Disease control ENROLLING_BY_INVITATIONThe Remission Evaluation of Metabolic Interventions in Type 2 diabetes (REMIT) program incorporates a non-surgical-remission-inducing therapeutic approach, pairing health coaching with physician-led pharmacotherapy. This approach has been tested in 5 multi-cite trials (1 pilot, 3…
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for tough prostate cancer: drug combo trial launches
Disease control Recruiting nowThis study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or docetaxel in biomarker-selected participants with metastatic castrate-resistant prosta…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for rare lung cancer: targeted drug trial launches
Disease control Recruiting nowThis study is an open-label, randomized, multicenter phase II/III clinical trial designed to evaluate the efficacy, safety, and tolerability of Andamertinib with or without platinum-based chemothsrapy versus platinum-based chemotherapy in previously untreated participants with lo…
Phase: PHASE2 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Gene-Editing shot takes aim at inherited high cholesterol
Disease control Not yet recruitingThis study is an open-label, single ascending dose (SAD) study designed to evaluate the safety and tolerability of ART002g1 in patients with heterozygous familial hypercholesterolemia (HeFH) who require further reduction in low-density lipoprotein cholesterol (LDL-C). ART002g1 us…
Phase: EARLY_PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could your own fat cells fight Alzheimer's? new trial aims to find out
Disease control Recruiting nowThe goal of this clinical trial is to learn if stem cell therapy works to treat brain inflammation in adults. Inflammation in the brain may be involved in adults who have memory or thinking problems. The stem cells will be taken from participant's fat samples, processed and given…
Phase: PHASE1, PHASE2 • Sponsor: Paul E Schulz • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New combo therapy targets tough bile duct cancer
Disease control Not yet recruiting(1) Primary efficacy endpoint: Objective Response Rate (ORR) after 2 treatment cycles. ORR is defined as the proportion of subjects with complete response (CR) and partial response (PR) among all subjects. (2) Secondary efficacy endpoints include Progression-Free Survival (PFS), …
Phase: PHASE2 • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a flower extract heal parasitic skin ulcers? new trial seeks answers
Disease control Recruiting nowCutaneous leishmaniasis (CL) is a parasitic disease caused by more than 20 different species of the protozoan parasite Leishmania. CL usually begins with a papule at the site of the sandfly bite, which enlarges to form a nodule that progresses to an ulceration, or a scaly or wart…
Phase: PHASE3 • Sponsor: Universidad de Antioquia • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a 3-Week radiation course beat the standard for cervical cancer?
Disease control Recruiting nowThis phase II trial compares the effect of hypofractionated radiotherapy (HFRT) to conventional fractionated radiotherapy (CFRT) when given in combination with cisplatin and brachytherapy in patients with stage IB3, II, or III cervical cancer. Radiation therapy uses high energy x…
Phase: PHASE2 • Sponsor: Uganda Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill shows promise against tough lung cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety and recommended dose of TRI-611 when administered to adults with ALK-positive non-small cell lung cancer (NSCLC). The trial will also evaluate the antitumor activity of TRI-611 in adults with ALK-positive NSCLC. The st…
Phase: PHASE1, PHASE2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
AI eye doctor: new model diagnoses diseases from photos
Diagnosis Recruiting nowAccurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter cli…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Which steroid works best for severe pneumonia? major trial aims to find out
Disease control Recruiting nowThe goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main …
Phase: PHASE4 • Sponsor: Copenhagen Respiratory Research • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for lung cancer patients: experimental drug SYS6010 faces off against chemotherapy
Disease control Not yet recruitingThis is a randomized, open-label, multicenter Phase III clinical trial, designed to evaluate the efficacy and safety of SYS6010 versus docetaxel in participants with Locally Advanced or Metastatic EGFR Wild-type Non-squamous Non-small Cell Lung Cancer who Have Failed Standard The…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC